Drug Safety Announcement Blitz Highlights Gottlieb's PR Savvy As Shutdown Drags On

Release of several different safety announcements showcases US FDA Commissioner Gottlieb's efforts to quell potential public concerns with an active communication strategy. 

FDA entrance sign 2016

A muscular public communications strategy has been one of the cornerstones of US FDA Commissioner Scott Gottlieb's tenure as head of the agency. And he is now using his now using his PR skills to home in on a topic of public interest as the federal government slogs through its third week of the shutdown: medical product safety.

While sponsors have begun to wonder whether the government shutdown will ultimately impact their drug review clocks, Gottlieb has done...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet